Try For Free 7-Day Free Trial
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Company operates through three segments: Pharmaceuticals, Alcon, and Sandoz. Novartis was founded in 1996 and is based in Basel, Switzerland.
|Overall||21 of 27|
|Sector (Life Science)||17 of 22|
|Type (Add-on Acquisition)||17 of 23|
|State (New Jersey)||1 of 1|
|Country (United States)||17 of 21|
|Year (2019)||3 of 3|
|Size (of disclosed)||1 of 14|
Novartis AG - TOBRADEX & NATACYN
Novartis AG's TOBRADEX is a fixed-dose topical antibiotic and corticosteroid combination indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Novartis AG's NATACYN is indicated for the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.
Amblyotech, Inc. is a digital therapeutics software company, which develops active and passive video therapies to treat amblyopia ("lazy eye"), a debilitating ocular condition that affects 3% of the global population and is a leading cause of monocular blindness. Amblyotech was founded in 2013 and is based in United States.